These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 1904012

  • 1. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA, Herman TS, Tanaka J, Dezube B, Pardee A, Frei E.
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [Abstract] [Full Text] [Related]

  • 2. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J, Teicher BA, Herman TS, Holden SA, Dezube B, Frei E.
    Int J Cancer; 1991 Jun 19; 48(4):631-7. PubMed ID: 2045206
    [Abstract] [Full Text] [Related]

  • 3. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E.
    Cancer Res; 1991 Feb 15; 51(4):1086-91. PubMed ID: 1825474
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA, Bernal SD, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Feb 15; 21(4):281-5. PubMed ID: 3131032
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA, Holden SA, Rose CM.
    Int J Cancer; 1986 Aug 15; 38(2):285-8. PubMed ID: 3089945
    [Abstract] [Full Text] [Related]

  • 7. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
    Teicher BA, Holden SA, Cathcart KN, Herman TS.
    J Natl Cancer Inst; 1988 Jun 15; 80(8):599-603. PubMed ID: 2453675
    [Abstract] [Full Text] [Related]

  • 8. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA, Holden SA.
    Cancer Treat Rep; 1987 Feb 15; 71(2):173-7. PubMed ID: 3100035
    [Abstract] [Full Text] [Related]

  • 9. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA, Holden SA, Jacobs JL.
    Cancer Res; 1987 Jan 15; 47(2):513-8. PubMed ID: 3098413
    [Abstract] [Full Text] [Related]

  • 10. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA, Holden SA, Herman TS, Frei E.
    Semin Oncol; 1991 Apr 15; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination of etanidazole with cyclophosphamide and platinum complexes.
    Teicher BA, Herman TS, Shulman L, Bubley G, Coleman CN, Frei E.
    Cancer Chemother Pharmacol; 1991 Apr 15; 28(3):153-8. PubMed ID: 1830248
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D.
    J Cancer Res Clin Oncol; 1992 Apr 15; 118(7):509-14. PubMed ID: 1624542
    [Abstract] [Full Text] [Related]

  • 17. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA, Crawford JM, Holden SA, Cathcart KN.
    Cancer Res; 1987 Oct 01; 47(19):5036-41. PubMed ID: 3113727
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA, Herman TS, Teicher BA.
    Radiother Oncol; 1990 May 01; 18(1):59-70. PubMed ID: 2113698
    [Abstract] [Full Text] [Related]

  • 20. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
    Teicher BA, Holden SA, Rose CM.
    J Natl Cancer Inst; 1985 Dec 01; 75(6):1129-33. PubMed ID: 3934448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.